PAIN — Vector Science and Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$91.96m
- CA$91.89m
Annual balance sheet for Vector Science and Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.115 | 0.282 | 0.235 | 0.197 | 0.067 |
| Net Total Receivables | 0 | 0.004 | 0.006 | 0.009 | 0.006 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.125 | 0.286 | 0.241 | 0.206 | 0.097 |
| Total Assets | 0.125 | 0.286 | 0.241 | 0.206 | 0.097 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.008 | 0.015 | 0.016 | 0.031 | 0.04 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.008 | 0.015 | 0.016 | 0.031 | 0.04 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.117 | 0.271 | 0.226 | 0.175 | 0.057 |
| Total Liabilities & Shareholders' Equity | 0.125 | 0.286 | 0.241 | 0.206 | 0.097 |
| Total Common Shares Outstanding |